Cell & Gene Therapy

  1. Adapting A rcAAV Assay For Commercial Manufacturing 5/15/2025

    Witness how to implement sensitive, cell-based qPCR assays to reliably detect rcAAVs and safeguard the integrity of your rAAV gene therapy manufacturing process.

  2. Pioneering Plasmid-IQ Design 5/13/2025

    Gain insights into the significance of plasmid design in viral vector production and the use of analytical assays and Next-Generation Sequencing for plasmid verification.

  3. SK pharmteco Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

    Our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.

  4. SK pharmteco Capacity Update April 2025: Analytical Services 4/22/2025

    Get the quality, compliance, and accelerated development support you need for your small molecule and cell and gene therapy program with our advanced analytical testing services.

  5. Revolutionizing Plasmid Design With Trusted Expertise 4/11/2025

    Optimize your plasmid design to enhance performance, simplify scale-up, and meet your development goals with confidence.

  6. Overcoming Plasmid Design Challenges With Expert Support 4/11/2025

    Learn how strategic plasmid design and specialized consulting services can help overcome engineering challenges and accelerate therapeutic innovation.

  7. Transforming Viral Vector Manufacturing With Next-Generation CGMP Plasmids Platform 4/11/2025

    Watch as experts explore key innovations in plasmid design and production, highlighting how these advancements can directly enhance biomanufacturing workflows.

  8. CGMP-Validated RCL Assay Used For Release Testing Of Manufactured Viruses, Gene Mediated Cell Therapy Products 3/5/2025

    Ensure the safety and efficacy of lentiviral-based therapies by addressing the risks of replication-competent lentiviruses (RCLs) through advanced monitoring and control strategies.

  9. cGMP-Ready Clonal HEK293 Cell Line For AAV, Lentiviral, And Adenoviral Vector Production 11/7/2024

    See how this advanced SKPT-HEK293 4G9 was able to provide a robust, CGMP-ready solution for efficient viral vector production, supporting a range of AAV serotypes and CAR-T Lenti-viral vectors for scalable manufacturing.

  10. SK pharmteco Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

    Check out our enhanced capacity and expertise in supporting CGT projects, offering end-to-end solutions from viral vector and plasmid development to GMP manufacturing and regulatory support.